https://www.selleckchem.com/products/sbi-115.html
IOP decreased from 18.3±5.7 mm Hg to 15.9±4.6 (P0.001) and glaucoma medication usage decreased from 1.9±1.1 to 1.1±1.1 (P0.001) at POY1. Eyes that underwent prior SLT experienced less of a decrease in IOP when compared with eyes without prior SLT, but IOP at POY1 was not significantly different between these groups. Both groups had a similar reduction in medication usage. The most common complications were IOP spikes on postoperative day 1 and microhyphemas. In this cohort, there was a significant decrease in IOP and medication